JPWO2020166527A1 - 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法 - Google Patents

乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法 Download PDF

Info

Publication number
JPWO2020166527A1
JPWO2020166527A1 JP2020572231A JP2020572231A JPWO2020166527A1 JP WO2020166527 A1 JPWO2020166527 A1 JP WO2020166527A1 JP 2020572231 A JP2020572231 A JP 2020572231A JP 2020572231 A JP2020572231 A JP 2020572231A JP WO2020166527 A1 JPWO2020166527 A1 JP WO2020166527A1
Authority
JP
Japan
Prior art keywords
infants
food
drink
infant
nicotinamide mononucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572231A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020166527A5 (https=
Inventor
めぐみ 田中
経丸 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPWO2020166527A1 publication Critical patent/JPWO2020166527A1/ja
Publication of JPWO2020166527A5 publication Critical patent/JPWO2020166527A5/ja
Priority to JP2023109306A priority Critical patent/JP2023123785A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/18—Milk in dried and compressed or semi-solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A23L33/145—Extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2020572231A 2019-02-12 2020-02-07 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法 Pending JPWO2020166527A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023109306A JP2023123785A (ja) 2019-02-12 2023-07-03 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019022222 2019-02-12
JP2019022222 2019-02-12
PCT/JP2020/004947 WO2020166527A1 (ja) 2019-02-12 2020-02-07 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023109306A Division JP2023123785A (ja) 2019-02-12 2023-07-03 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法

Publications (2)

Publication Number Publication Date
JPWO2020166527A1 true JPWO2020166527A1 (ja) 2021-12-16
JPWO2020166527A5 JPWO2020166527A5 (https=) 2022-11-02

Family

ID=72044508

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020572231A Pending JPWO2020166527A1 (ja) 2019-02-12 2020-02-07 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法
JP2023109306A Pending JP2023123785A (ja) 2019-02-12 2023-07-03 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023109306A Pending JP2023123785A (ja) 2019-02-12 2023-07-03 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法

Country Status (6)

Country Link
US (1) US20220095665A1 (https=)
EP (1) EP3925450A4 (https=)
JP (2) JPWO2020166527A1 (https=)
KR (1) KR20220002260A (https=)
CN (1) CN113438896B (https=)
WO (1) WO2020166527A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220168271A1 (en) * 2019-03-29 2022-06-02 Societe Des Produits Nestle S.A. Compositions and methods for increasing t cell function
CN111557949B (zh) * 2020-05-28 2022-08-26 深圳爱生生命科技有限公司 含有富氢水和/或nmn的药物或保健品及其制备方法
KR20250038714A (ko) * 2022-07-21 2025-03-19 메구미 타나카 니코틴아미드모노뉴클레오티드가 봉입되어 있는 장내세균총 개선용 장용성 캡슐제
JP2025183464A (ja) * 2022-11-04 2025-12-17 ミライラボバイオサイエンス株式会社 イヌの腸内細菌叢改善用剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100104727A1 (en) * 2008-10-24 2010-04-29 Mead Johnson & Co. Methods For Preserving Endogenous TGF-Beta
JP2015519388A (ja) * 2012-06-15 2015-07-09 コナリス リサーチ インスティチュート アーゲー ニコチン酸および／もしくはニコチンアミドならびに／またはトリプトファンを含有する、腸内微生物叢によい影響を及ぼすための医薬組成物
WO2017181102A1 (en) * 2016-04-14 2017-10-19 ChromaDex Inc. Use of nicotinamide riboside, nicotinic acid riboside, nicotinamide mononucleotide, and nicotinoyl compound derivatives in infant formula

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0685684B2 (ja) 1986-01-17 1994-11-02 雪印乳業株式会社 ガングリオシド添加粉乳
JP2514375B2 (ja) 1987-08-26 1996-07-10 雪印乳業株式会社 感染防御能を付与した育児用粉乳
JP2514375Y2 (ja) 1991-05-28 1996-10-16 松下電工株式会社 床材の支持脚
JP3087394B2 (ja) 1991-11-19 2000-09-11 日本電気株式会社 ２進算術符号器
JP4008974B2 (ja) 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
JP6641240B2 (ja) * 2016-06-27 2020-02-05 オリエンタル酵母工業株式会社 ナチュラルキラー細胞の活性化剤
CN109090614A (zh) * 2018-08-21 2018-12-28 大连美耶国际贸易有限公司 具有美容、缓解疲劳、增强免疫力功效的保健品

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100104727A1 (en) * 2008-10-24 2010-04-29 Mead Johnson & Co. Methods For Preserving Endogenous TGF-Beta
JP2015519388A (ja) * 2012-06-15 2015-07-09 コナリス リサーチ インスティチュート アーゲー ニコチン酸および／もしくはニコチンアミドならびに／またはトリプトファンを含有する、腸内微生物叢によい影響を及ぼすための医薬組成物
WO2017181102A1 (en) * 2016-04-14 2017-10-19 ChromaDex Inc. Use of nicotinamide riboside, nicotinic acid riboside, nicotinamide mononucleotide, and nicotinoyl compound derivatives in infant formula

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中村友彦, 小児科臨床, vol. 67(12), JPN6020014055, 2014, JP, pages 2414 - 134, ISSN: 0005028296 *

Also Published As

Publication number Publication date
CN113438896B (zh) 2024-10-29
EP3925450A1 (en) 2021-12-22
KR20220002260A (ko) 2022-01-06
WO2020166527A1 (ja) 2020-08-20
US20220095665A1 (en) 2022-03-31
JP2023123785A (ja) 2023-09-05
CN113438896A (zh) 2021-09-24
EP3925450A4 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
JP2023123785A (ja) 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法
EP1571923B1 (en) Prebiotic compositions
RU2430631C2 (ru) Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
JP4793533B2 (ja) ポリデキストロースでの免疫系の刺激
WO2008037839A1 (en) Method for producing products containing galactooligosaccharides and use thereof
US20110274672A1 (en) Sialic acid producing bacteria
KR20170044701A (ko) 지소화성 지속형 에너지 보급제
AU2019237674A1 (en) Composition for enhancing breast milk component
JPWO2007114499A1 (ja) 抗脂肪蓄積用組成物
AU2020403386A1 (en) Compositions comprising human milk oligosaccharides for use in a subject to support language development
JP2023062564A (ja) 組成物
TW202128190A (zh) 用於預防氣喘的包含2’-岩藻糖基乳糖之組成物
EP3888661B1 (en) Compositions comprising 2 -fucosyllactose to prevent viral infections
CN112806577B (zh) 产丁酸的益生元益生菌增效组合
CN117715540A (zh) 用于喂养接受婴儿配方和人母乳的婴儿的婴儿配方
JP3886915B2 (ja) ペプチドミルク
JP7025465B2 (ja) フルクトース誘導性疾患の予防又は改善用組成物
JP2025149158A (ja) 脂質吸収促進剤
JP2024152695A (ja) ビフィズス菌の増殖用組成物および増殖方法ならびに乳酸および／またはピルビン酸の増加用組成物および増加方法
JP4049278B2 (ja) 腸内代謝改善剤
EP4701441A1 (en) Composition for use in a subject
WO2025053158A1 (ja) ファスコラークトバクテリウム属細菌の増殖促進用組成物
AU2024264071A1 (en) Compositions and methods for improving immune health
WO2022255284A1 (ja) 妊婦用経口投与剤
JP2006137746A (ja) オレキシン誘導組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221025

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221025

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230404